-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Monday's Pre-Market Session
Share
Listen to the news

Gainers

  • Tango Therapeutics (NASDAQ:TNGX) shares increased by 44.5% to $29.23 during Monday's pre-market session. The company's market cap stands at $2.9 billion.
  • QTREX Quantum (NASDAQ:QTEX) shares rose 21.83% to $1.73. The market value of their outstanding shares is at $61.8 million.
  • Cypherpunk Technologies (NASDAQ:CYPH) stock rose 20.47% to $0.62. The market value of their outstanding shares is at $55.2 million.
  • Nyxoah (NASDAQ:NYXH) stock increased by 17.17% to $1.7. The company's market cap stands at $64.8 million.
  • Sensei Biotherapeutics (NASDAQ:SNSE) shares increased by 16.72% to $17.1. The market value of their outstanding shares is at $19.6 million.
  • Nurix Therapeutics (NASDAQ:NRIX) stock moved upwards by 15.5% to $16.91. The market value of their outstanding shares is at $1.5 billion.

Losers

  • Inotiv (NASDAQ:NOTV) stock declined by 24.0% to $0.13 during Monday's pre-market session. The company's market cap stands at $5.7 million.
  • Clearmind Medicine (NASDAQ:CMND) stock declined by 21.61% to $3.12. The company's market cap stands at $4.0 million.
  • Aditxt (NASDAQ:ADTX) stock fell 21.02% to $0.05.
  • Nuwellis (NASDAQ:NUWE) stock decreased by 18.37% to $0.14.
  • VolitionRX (AMEX:VNRX) shares decreased by 16.21% to $1.5. The company's market cap stands at $14.9 million.
  • NewGenIvf Group (NASDAQ:NIVF) stock declined by 15.68% to $0.54. The market value of their outstanding shares is at $1.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending